Healthcare Triangle, Inc.
HCTI
$2.42
$0.146.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -45.90% | -58.90% | -64.77% | -55.75% | -47.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -45.90% | -58.90% | -64.77% | -55.75% | -47.29% |
| Cost of Revenue | -40.03% | -57.29% | -66.68% | -59.17% | -48.87% |
| Gross Profit | -65.02% | -64.42% | -57.36% | -41.03% | -41.37% |
| SG&A Expenses | -23.48% | -35.68% | -39.14% | -39.62% | -34.77% |
| Depreciation & Amortization | -117.60% | -70.28% | -43.23% | -82.08% | -72.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.85% | -50.78% | -58.02% | -57.79% | -50.95% |
| Operating Income | -3.51% | 1.07% | 20.53% | 64.70% | 63.84% |
| Income Before Tax | 18.95% | 20.04% | 31.08% | 46.83% | 42.74% |
| Income Tax Expenses | -50.00% | -56.25% | -80.00% | -75.00% | -83.56% |
| Earnings from Continuing Operations | 19.00% | 20.12% | 31.28% | 46.93% | 42.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.00% | 20.12% | 31.28% | 46.93% | 42.98% |
| EBIT | -3.51% | 1.07% | 20.53% | 64.70% | 63.84% |
| EBITDA | -294.48% | -254.21% | -380.66% | 125.19% | 123.76% |
| EPS Basic | 59.87% | 46.56% | 44.21% | 54.08% | 49.46% |
| Normalized Basic EPS | 44.81% | 28.53% | 29.40% | 71.49% | 66.17% |
| EPS Diluted | 59.87% | 46.56% | 44.21% | 54.08% | 49.46% |
| Normalized Diluted EPS | 44.81% | 28.53% | 29.40% | 71.49% | 66.17% |
| Average Basic Shares Outstanding | 3,249.66% | 55.93% | 26.34% | 17.27% | 13.46% |
| Average Diluted Shares Outstanding | 3,249.66% | 55.93% | 26.34% | 17.27% | 13.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |